Earnings Call · Q1 FY2025·2025-05-08

Q1 25EPS -7.14%·Rev n/aQ4 24EPS +18.42%·Rev n/aQ3 24EPS -30.77%·Rev n/aQ2 24EPS +7.14%·Rev n/a⚠ consensus missing

AbCellera Biologics Inc. ABCL

Tryn Stimart — Chief Legal and Compliance Officer

Carl Hansen — President and Chief Executive Officer

Andrew Booth — Chief Financial Officer

0.0%1d on move date−0.7% vs SPY3d+2.5%5d+2.0%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more ABCL calls or request research access.

More ABCL calls Browse calls Request research access